Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017, University of Southampton
Mammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.

A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Breast is the second leading cause of cancer-related death in women, with nearly 450,000 deaths per year from the disease worldwide. However, women aged 15-39 at diagnosis have a poorer chance of surviving their cancer than older women (although survival rates for the disease are generally high).

This difference is partly due to the higher incidence of adverse tumour types that occur in , but age is an independent risk factor even after accounting for differences in tumour type and treatment.

The Southampton study - one of the largest ever undertaken into the link between genes and survival in women aged 40 or under at diagnosis - looked at which factors, other than the features of the cancer tissue, might contribute to the poorer survival rate in younger women.

Scientists discovered that variations called (SNPs) in a particular gene, ADAMTSL1, increased the risk of disease progression - but only in patients with early onset of the disease. SNPs describe locations in the genome (a person's entire genetic instructions) where a single nucleotide of the DNA sequence may vary among individuals. Studies such as this look for a link between this type of genetic variation and survival.

The collaborative study is published in the journal Nature Communications. Lead author Dr William Tapper said that the findings could eventually be used to improve the accuracy of estimates of disease progression, helping clinicians and patients to choose the most effective treatments.

"This is a significant discovery with exciting implications for the future diagnosis and treatment of early-onset ," said Dr Tapper.

"Our findings increase our understanding of the genes and pathways that are involved in , and may provide new targets for the development of novel therapies.

"In the short to medium-term, this genetic factor may be used to improve prognostic models. In the long-term, when more is known about the mechanism underlying this association and its relationship with treatment response, it may have an influence on approaches to the most effective cancer treatments."

Dr Tapper added that additional studies would be needed to fully investigate the findings and their implications.

Explore further: 'Missing DNA' could hold clue to why some get breast cancer young

More information: Latha Kadalayil et al, Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women, Nature Communications (2017). DOI: 10.1038/s41467-017-01775-y

Related Stories

'Missing DNA' could hold clue to why some get breast cancer young

May 29, 2017
A University of Otago, Christchurch, discovery of missing DNA in women who develop breast cancer at a young age could hold the key to helping them beat the disease.

Breast cancer statistics, 2017: Gap in death rates between whites, blacks closing in several states

October 3, 2017
Overall breast cancer death rates dropped 39 percent between 1989 and 2015, averting 322,600 breast cancer deaths during those 26 years. And while black women continue to have higher breast cancer death rates than whites ...

Smoking negatively impacts long-term survival after breast cancer

September 21, 2017
A new study published in JNCI Cancer Spectrum finds that smoking negatively impacts long-term survival after breast cancer. Quitting smoking after diagnosis may reduce the risk of dying from breast cancer.

Pregnancy not dangerous for women who had breast cancer

June 4, 2017
Becoming pregnant after a diagnosis of breast cancer does not raise the risk of the cancer returning, said the largest study of its kind to date, released Saturday at a major cancer conference.

Breast cancer awareness: What women need to know

September 28, 2016
As national Breast Cancer Awareness Months begins next week, breast health expert Dr. Sharon Koehler of New York Institute of Technology College of Osteopathic Medicine, says women need to know the following five things:

Protein to control breast cancer progression identified

July 5, 2017
Switching off a protein produced in breast cancer cells can stop cancer progression, researchers from The University of Queensland have found.

Recommended for you

Researchers artificially generate immune cells integral to creating cancer vaccines

August 14, 2018
For the first time, Mount Sinai researchers have identified a way to make large numbers of immune cells that can help prevent cancer reoccurrence, according to a study published in August in Cell Reports.

Chemicals found in vegetables prevent colon cancer in mice

August 14, 2018
Chemicals produced by vegetables such as kale, cabbage and broccoli could help to maintain a healthy gut and prevent colon cancer, a new study from the Francis Crick Institute shows.

Lymphatic vessels unexpectedly promote the spread of cancer metastases

August 14, 2018
Lymphatic vessels actively contribute to the spread of cancer metastases from various organs. This unexpected realisation is the result of a joint study by researchers from ETH Zurich and the University Hospital Zurich as ...

Ovarian cancer genetics unravelled

August 14, 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease, and could be used to personalise treatment in future.

Researchers uncover a major new vulnerability of childhood leukemia

August 14, 2018
Childhood leukemia is a diagnosis that no family ever wants to endure. While the treatment of most types of leukemia has improved steadily over the years, a few specific types remain very difficult to treat. One of these ...

Stress hormone is key factor in failure of immune system to prevent leukemia

August 14, 2018
The human stress hormone cortisol has been identified by scientists at the University of Kent as a key factor when the immune system fails to prevent leukemia taking hold.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.